These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1538576)

  • 21. Effect of metoprolol on the beta-adrenoceptor density of lymphocytes in patients with dilated cardiomyopathy.
    Ishida S; Makino N; Masutomo K; Hata T; Yanaga T
    Am Heart J; 1993 May; 125(5 Pt 1):1311-5. PubMed ID: 8386904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.
    Metra M; Giubbini R; Nodari S; Boldi E; Modena MG; Dei Cas L
    Circulation; 2000 Aug; 102(5):546-51. PubMed ID: 10920067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of long-term adrenergic beta-blockade on left ventricular diastolic filling in patients with acute myocardial infarction.
    Poulsen SH; Jensen SE; Egstrup K
    Am Heart J; 1999 Oct; 138(4 Pt 1):710-20. PubMed ID: 10502218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
    Waagstein F; Bristow MR; Swedberg K; Camerini F; Fowler MB; Silver MA; Gilbert EM; Johnson MR; Goss FG; Hjalmarson A
    Lancet; 1993 Dec; 342(8885):1441-6. PubMed ID: 7902479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study.
    Eichhorn EJ; Heesch CM; Barnett JH; Alvarez LG; Fass SM; Grayburn PA; Hatfield BA; Marcoux LG; Malloy CR
    J Am Coll Cardiol; 1994 Nov; 24(5):1310-20. PubMed ID: 7930255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of repeated echocardiographic evaluation in patients with idiopathic dilated cardiomyopathy during treatment with metoprolol or captopril.
    Jansson K; Dahlström U; Karlberg KE; Karlsson E; Nyquist O; Nylander E
    Scand Cardiovasc J; 2000 Jun; 34(3):293-300. PubMed ID: 10935777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of long-term beta-blocker therapy for dilated cardiomyopathy--echocardiographical follow-up.
    Fukunami M; Hashimura K; Ohmori M; Ikeda T; Umemoto K; Kumagai K; Sakai A; Yamada T; Kondoh N; Minamino T
    Cardiovasc Drugs Ther; 1991 Apr; 5(2):463-9. PubMed ID: 1677261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dilated cardiomyopathy with hypertension: prevalence and response to high-dose β1-adrenoceptor antagonist therapy.
    Zheng X; Chen S; Wang J; Yang T; Chen Y
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):945-9. PubMed ID: 19473337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy.
    Hirooka K; Yasumura Y; Ishida Y; Hanatani A; Nakatani S; Komamura K; Hori M; Yamagishi M; Miyatake K
    Jpn Circ J; 2001 Nov; 65(11):931-6. PubMed ID: 11716241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Nebivolol on left ventricular function and exercise capacity in patients with non-ischaemic dilated cardiomyopathy. A randomised placebo-controlled study.
    Patrianakos AP; Parthenakis FI; Mavrakis HE; Saatsaki M; Diakakis GF; Chlouverakis GI; Vardas PE
    Hellenic J Cardiol; 2005; 46(3):199-207. PubMed ID: 15981555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical usefulness of 123I meta-iodobenzylguanidine imaging in predicting the effectiveness of beta blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment.
    Kakuchi H; Sasaki T; Ishida Y; Komamura K; Miyatake K
    Heart; 1999 Feb; 81(2):148-52. PubMed ID: 9922349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment.
    Andersson B; Hamm C; Persson S; Wikström G; Sinagra G; Hjalmarson A; Waagstein F
    J Am Coll Cardiol; 1994 May; 23(6):1397-404. PubMed ID: 8176099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early changes in longitudinal performance predict future improvement in global left ventricular function during long term beta adrenergic blockade.
    Andersson B; Waagstein F; Caidahl K; Eurenius I; Täng MS; Wikh R
    Heart; 2000 Dec; 84(6):599-605. PubMed ID: 11083735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early reduction in plasma norepinephrine during beta-blocking therapy with metoprolol in chronic heart failure.
    Santostasi G; Fraccarollo D; Dorigo P; Egloff C; Miraglia G; Marinato PG; Villanova C; Fasoli G; Maragno I
    J Card Fail; 1998 Sep; 4(3):177-84. PubMed ID: 9754588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MIC trial: metoprolol in patients with mild to moderate heart failure: effects on ventricular function and cardiopulmonary exercise testing.
    Genth-Zotz S; Zotz RJ; Sigmund M; Hanrath P; Hartmann D; Böhm M; Waagstein F; Treese N; Meyer J; Darius H
    Eur J Heart Fail; 2000 Jun; 2(2):175-81. PubMed ID: 10856731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of beta-adrenergic blocking therapy on left ventricular diastolic relaxation properties in patients with dilated cardiomyopathy.
    Kim MH; Devlin WH; Das SK; Petrusha J; Montgomery D; Starling MR
    Circulation; 1999 Aug; 100(7):729-35. PubMed ID: 10449695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-converting enzyme inhibitors and beta-blockers in long-term treatment of dilated cardiomyopathy.
    Regitz-Zagrosek V; Leuchs B; Krülls-Münch J; Fleck E
    Am Heart J; 1995 Apr; 129(4):754-61. PubMed ID: 7900628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy.
    Hara Y; Inoue K; Ogimoto A; Ohtsuka T; Shigematsu Y; Nakata S; Higaki J
    Cardiology; 2005; 104(1):16-21. PubMed ID: 15942178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy.
    Wisenbaugh T; Katz I; Davis J; Essop R; Skoularigis J; Middlemost S; Röthlisberger C; Skudicky D; Sareli P
    J Am Coll Cardiol; 1993 Apr; 21(5):1094-100. PubMed ID: 8096228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.